Avista Healthcare Public Acquisition Corp. Warrants
AHPAW
AHPAW was delisted on the 30th of October, 2018.
0 hedge funds and large institutions have $0 invested in Avista Healthcare Public Acquisition Corp. Warrants in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 23 closing their positions.
100% less funds holding
Funds holding: 23 → 0 (-23)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $29M → $0 (-$29M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 23
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AGC
Angelo Gordon & Co
New York
|
-$25.1M |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$960K |
| 3 |
FTCM
Fir Tree Capital Management
New York
|
-$360K |
| 4 |
HCM
Highbridge Capital Management
New York
|
-$324K |
| 5 |
MCM
Moore Capital Management
New York
|
-$298K |
AHPAW Hedge Fund Activity: Q4 2018 in Review
0 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Avista Healthcare Public Acquisition Corp. Warrants (AHPAW) for Q4 2018, worth a combined $0 — down 100% from $29M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of AHPAW and 0 opened new positions — a net loss of 23 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Angelo Gordon & Co, exiting entirely with an estimated $25.1M sold.
- 0 institutional investors held Avista Healthcare Public Acquisition Corp. Warrants (AHPAW) as of Q4 2018, down from 23 in Q3 2018.
- Funds reported $0 of Avista Healthcare Public Acquisition Corp. Warrants stock for Q4 2018, down 100% quarter-over-quarter.
- 0 funds opened new Avista Healthcare Public Acquisition Corp. Warrants positions in Q4 2018 and 23 closed out, a net change of -23 holders.
- The largest Avista Healthcare Public Acquisition Corp. Warrants seller in Q4 2018 was Angelo Gordon & Co, an estimated $25.1M sold.
Based on aggregated 13F filings for Q4 2018.